TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ACAD

ACADIA Pharmaceuticals Inc

Healthcare · Biotechnology

27.30$ -0.6% vs. previous close Closing price · As of: Sep 18, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of ACADIA Pharmaceuticals Inc (ACAD) with date, type and a link to the original document.

Filings ACAD
Date Type Filing Original
09/11/2026 Current report (8-K) ACADIA PHARMACEUTICALS INC (ACAD): Other Events; Financial Statements and Exhibits View report ↗
08/04/2026 Current report (8-K) ACADIA PHARMACEUTICALS INC (ACAD): Results of Operations and Financial Condition; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?